5-[(3S)-3-aminopyrrolidin-1-yl]-6-bromo-3-methylpyrazolo[1,5-a]pyrimidin-7-amine;5-[(3S)-3-aminopyrrolidin-1-yl]-6-chloro-3-methylpyrazolo[1,5-a]pyrimidin-7-amine;6-bromo-5-cyclohexyl-3-methylpyrazolo[1,5-a]pyrimidin-7-amine;bis(5-cyclohexyl-3-(morpholin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine);5-cyclohexyl-3-[(E)-2-phenylethenyl]pyrazolo[1,5-a]pyrimidin-7-amine
C89H119Br2ClN30O2 — CID 159427149
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[(3S)-3-aminopyrrolidin-1-yl]-6-bromo-3-methylpyrazolo[1,5-a]pyrimidin-7-amine;5-[(3S)-3-aminopyrrolidin-1-yl]-6-chloro-3-methylpyrazolo[1,5-a]pyrimidin-7-amine;6-bromo-5-cyclohexyl-3-methylpyrazolo[1,5-a]pyrimidin-7-amine;bis(5-cyclohexyl-3-(morpholin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine);5-cyclohexyl-3-[(E)-2-phenylethenyl]pyrazolo[1,5-a]pyrimidin-7-amine
5-[(3S)-3-aminopyrrolidin-1-yl]-6-bromo-3-methylpyrazolo[1,5-a]pyrimidin-7-amine;5-[(3S)-3-aminopyrrolidin-1-yl]-6-chloro-3-methylpyrazolo[1,5-a]pyrimidin-7-amine;6-bromo-5-cyclohexyl-3-methylpyrazolo[1,5-a]pyrimidin-7-amine;bis(5-cyclohexyl-3-(morpholin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine);5-cyclohexyl-3-[(E)-2-phenylethenyl]pyrazolo[1,5-a]pyrimidin-7-amine (PubChem CID 159427149) has the molecular formula C89H119Br2ClN30O2 and a molecular weight of 1836.40 g/mol. Its IUPAC name is 5-[(3S)-3-aminopyrrolidin-1-yl]-6-bromo-3-methylpyrazolo[1,5-a]pyrimidin-7-amine;5-[(3S)-3-aminopyrrolidin-1-yl]-6-chloro-3-methylpyrazolo[1,5-a]pyrimidin-7-amine;6-bromo-5-cyclohexyl-3-methylpyrazolo[1,5-a]pyrimidin-7-amine;bis(5-cyclohexyl-3-(morpholin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine);5-cyclohexyl-3-[(E)-2-phenylethenyl]pyrazolo[1,5-a]pyrimidin-7-amine.
Molecular Properties
| Compound Name | 5-[(3S)-3-aminopyrrolidin-1-yl]-6-bromo-3-methylpyrazolo[1,5-a]pyrimidin-7-amine;5-[(3S)-3-aminopyrrolidin-1-yl]-6-chloro-3-methylpyrazolo[1,5-a]pyrimidin-7-amine;6-bromo-5-cyclohexyl-3-methylpyrazolo[1,5-a]pyrimidin-7-amine;bis(5-cyclohexyl-3-(morpholin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine);5-cyclohexyl-3-[(E)-2-phenylethenyl]pyrazolo[1,5-a]pyrimidin-7-amine |
|---|---|
| PubChem CID | 159427149 |
| Molecular Formula | C89H119Br2ClN30O2 |
| Molecular Weight | 1836.40 g/mol |
| Exact Mass | 1832.82 |
| IUPAC Name | 5-[(3S)-3-aminopyrrolidin-1-yl]-6-bromo-3-methylpyrazolo[1,5-a]pyrimidin-7-amine;5-[(3S)-3-aminopyrrolidin-1-yl]-6-chloro-3-methylpyrazolo[1,5-a]pyrimidin-7-amine;6-bromo-5-cyclohexyl-3-methylpyrazolo[1,5-a]pyrimidin-7-amine;bis(5-cyclohexyl-3-(morpholin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine);5-cyclohexyl-3-[(E)-2-phenylethenyl]pyrazolo[1,5-a]pyrimidin-7-amine |
| SMILES | Cc1cnn2c(N)c(Br)c(C3CCCCC3)nc12.Cc1cnn2c(N)c(Br)c(N3CC[C@H](N)C3)nc12.Cc1cnn2c(N)c(Cl)c(N3CC[C@H](N)C3)nc12.Nc1cc(C2CCCCC2)nc2c(/C=C/c3ccccc3)cnn12.Nc1cc(C2CCCCC2)nc2c(CN3CCOCC3)cnn12.Nc1cc(C2CCCCC2)nc2c(CN3CCOCC3)cnn12 |
| InChI | InChI=1S/C20H22N4.2C17H25N5O.C13H17BrN4.C11H15BrN6.C11H15ClN6/c21-19-13-18(16-9-5-2-6-10-16)23-20-17(14-22-24(19)20)12-11-15-7-3-1-4-8-15;2*18-16-10-15(13-4-2-1-3-5-13)20-17-14(11-19-22(16)17)12-21-6-8-23-9-7-21;1-8-7-16-18-12(15)10(14)11(17-13(8)18)9-5-3-2-4-6-9;2*1-6-4-15-18-9(14)8(12)11(16-10(6)18)17-3-2-7(13)5-17/h1,3-4,7-8,11-14,16H,2,5-6,9-10,21H2;2*10-11,13H,1-9,12,18H2;7,9H,2-6,15H2,1H3;2*4,7H,2-3,5,13-14H2,1H3/b12-11+;;;;;/t;;;;2*7-/m....00/s1 |
| InChIKey | LQMXHNYLSAJCDW-IIPNUHPYSA-N |
| XLogP | 14.07 |
| TPSA | 420.72 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 32 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 124 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1836.40 |
| LogP ≤ 5 | 14.07 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 32 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159427149 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.